Surgery Margins Found Sufficient Under 2 mm

A new study indicates that breast cancer recurrence risk remains low with margins thinner than 2 mm for most patients.

Updated on Sept. 28, 2026 in Cancer

Isometric editorial illustration showing a surgical scalpel and a tissue block, representing medical research findings on surgical margins.
A new study indicates that breast cancer recurrence risk remains low with surgical margins thinner than 2 mm for most patients, potentially enabling more tailored treatment plans. AI Illustration. Upload story photo >

Live Poll

Should medical guidelines for breast surgery be relaxed if patient-level data suggests lower risks than expected?

Researchers found that negative surgical margins under 2 mm do not significantly increase recurrence risk in most patients undergoing breast-conserving surgery. However, patients younger than 50 years with these thinner margins demonstrated a higher risk of recurrence.

Why it matters

The findings challenge the necessity of strict 2 mm negative margin guidelines for all patients. By evaluating real-world outcomes, the study provides evidence that may allow for more tailored surgical approaches depending on age.

In a study of 11,156 women, researchers observed that margins between 0.01 mm and 1.9 mm showed no significant recurrence difference compared to 2 mm margins. The study used data from the 2017 Commission on Cancer Special Study.

The players

Commission on Cancer

This program of the American College of Surgeons sets standards for quality cancer care and maintains comprehensive patient databases.

National Cancer Database

This clinical oncology outcomes database is a joint project between the Commission on Cancer and the American Cancer Society.

The details

The analysis focused on patients diagnosed between 2008 and 2015, tracking them for a median of 66.6 months. While positive margins correlated with a 2.06 hazard ratio for recurrence, smaller negative margins were largely effective, particularly when paired with radiotherapy.

Timeline

  1. Patients in the study were diagnosed between 2008 and 2015.

  2. The Commission on Cancer collected special study data in 2017.

  3. The research study was published in September 2026.

Health Landscape

This research follows a growing trend of utilizing the National Cancer Database to scrutinize established surgical guidelines with large-scale, patient-level clinical data. By reassessing long-standing protocols, the study advances efforts to reduce unnecessary re-excision surgeries while maintaining patient safety.

Patients may find that surgeons are more likely to accept thinner margins as sufficient, potentially reducing the need for secondary operations. Individuals under 50 should discuss these findings with their doctors, as they may remain at a higher risk of recurrence with thinner margins.

The takeaway

These results support a more nuanced approach to breast cancer surgery that considers patient age alongside surgical margins. Most patients can potentially avoid re-excision surgery if their margins are clear, even if they fall below the current 2 mm standard.

Further reading

For more information on current treatment standards, visit the United States Cancer section.

Source note: This article includes information reported by Medscape.

Live Poll

Should medical guidelines for breast surgery be relaxed if patient-level data suggests lower risks than expected?